Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Caladrius Biosciences Inc (NASDAQ:CLBS)

1.65
Delayed Data
As of Jul 31
 -0.08 / -4.62%
Today’s Change
1.63
Today|||52-Week Range
7.22
-56.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues4.5M4.1M5.3M3.2M
 
 
 
 
 
Cost of Goods Sold3.2M3.5M3.6M2.8M
 
 
 
 
 
Depreciation And Amortization543.2K590.6K608.6K604.4K
 
 
 
 
 
 
Operating ExpensesGross Income739.5K33.3K1.0M-268.4K
 
 
 
 
 
General Expenses13.2M16.3M16.6M17.8M
 
 
 
 
 
Research And Development5.8M8.4M10.1M6.8M
 
 
 
 
 
Total Operating Expenses16.9M20.4M20.8M21.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.4M-16.3M-15.6M-18.1M
 
 
 
 
 
Extraordinary Credit--0.004.2M--
 
 
Extraordinary Charge---690.0K---550.0K
 
 
 
Interest Expense On Debt105.9K183.5K372.2K551.0K
 
 
 
 
 
Other Expenses-185.7K2.7K-181.4K4.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.7M-17.1M-11.9M-19.2M
 
 
 
 
 
Income Taxes-47.4K-47.4K-246.4K-46.6K
 
 
 
 
 
Minority Interest-164.5K-202.4K-78.4K-44.6K
 
 
 
 
 
Net Income-12.6M-17.0M-11.6M-19.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.7M35.1M36.3M37.6M
 
 
 
 
 
Shares To Calculate EPS Diluted31.7M35.1M36.3M37.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.40-$0.48-$0.32-$0.51
 
 
 
 
 
EPS Diluted-$0.40-$0.48-$0.32-$0.51